adaptimmune's allogeneic or 'off-the-shelf' cell therapies.
Published 3 years ago • 35K plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
5:26
adaptimmune asgct 2021
-
53:30
replay of adaptimmune’s first live virtual event – our allogeneic platform
-
3:22
our research: a rich cell therapy pipeline for the future
-
13:16
adaptimmune
-
2:28
jo brewer talks about our off-the-shelf spear t-cell program
-
13:09
adaptimmune
-
2:53
adaptimmune spear t-cell mechanism of action video
-
19:24
adaptimmune reports updated surpass data at esmo 2021
-
14:57
adaptimmune
-
2:00:38
adaptimmune's symposium at ctos 2021– “spotlight on synovial sarcoma; where are we now? where next?”
-
12:13
adaptimmune
-
13:30
spear t-cells derived from stem cells kill cancer targets in vitro - data from asgct 2020
-
15:06
adaptimmune
-
12:06
adaptimmune
-
11:59
crispr therapeutics - allogeneic cell therapies
-
2:21
spearhead-2 trial design: combining spear t-cells with pembrolizumab
-
7:44
e. norry & d. williams present initial data from spearhead-1 trial
-
3:09
the current landscape of allogeneic car t-cell therapies